Customs issued directions for immediate clearance, establishing a precedent for consistent CDSCO exemption application at ports nationwide.
Resolved a systemic issue where customs authorities routinely demanded CDSCO NOCs for products explicitly exempted by the drug regulator. CBIC Member-level directive eliminates a clearance delay pattern blocking life sciences supply chains.